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Background: Leishmaniasis is a group of diseases with a variety of clinical manifestations. The form of the disease
is highly dependent on the infective Leishmania species and the immunological status of the host. The infectivity of
the parasite strain also plays an important role in the progression of the infection. The aim of this work is to
understand the influence of the natural infectivity of Leishmania strains in the outcome of visceral leishmaniasis.
Methods: In this study we have characterized four strains of L. infantum in terms of molecular typing, in vitro
cultivation and differentiation. Two strains were isolated from HIV+ patients with visceral leishmaniasis (Bibiano and
E390M), one strain was isolated from a cutaneous lesion in an immunocompetent patient (HL) and another internal
reference strain causative of visceral leishmaniasis (ST) also from an immunocompetent patient was used for
comparison. For this objective, we have compared their virulence by in vitro and in vivo infectivity in a murine
model of visceral leishmaniasis.
Results: Molecular typing unraveled a new k26 sequence attributed to MON-284 zymodeme and allowed the
generation of a molecular signature for the identification of each strain. In vitro cultivation enabled the production
of promastigotes with comparable growth curves and metacyclogenesis development. The HL strain was the most
infective, showing the highest parasite loads in vitro that were corroborated with the in vivo assays, 6 weeks post-
infection in BALB/c mice. The two strains isolated from HIV+ patients, both belonging to two different zymodemes,
revealed different kinetics of infection.
Conclusion: Differences in in vitro and in vivo infectivity found in the murine model were then attributed to
intrinsic characteristics of each strain. This work is supported by other studies that present the parasite’s inherent
features as factors for the multiplicity of clinical manifestations and severity of leishmaniasis.
Keywords: Leishmania infantum, Clinical isolates, Visceral leishmaniasis, Molecular typing, Metacyclogenesis,
Infectivity, Tropism* Correspondence: cordeiro@ibmc.up.pt
1Parasite Disease Group, Unit of Infection and Immunity, IBMC - Instituto de
Biologia Molecular e Celular, Universidade do Porto, Rua do Campo Alegre,
823, Porto 4150-180, Portugal
4Laboratório de Microbiologia, Departamento de Ciências Biológicas,
Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
Full list of author information is available at the end of the article
© 2013 Cunha et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Cunha et al. Parasites & Vectors 2013, 6:122 Page 2 of 14
http://www.parasitesandvectors.com/content/6/1/122Background
Parasites from the Leishmania genus are trypanosomatid
protozoans responsible for a group of diseases with a
broad range of clinical manifestations collectively known
as leishmaniasis (reviewed in [1-3]). The emergence of
leishmaniasis as an opportunistic infection in HIV+ pa-
tients in areas where both pathogens are endemic [4]
has generated new interest in leishmaniasis.
It is well known that species such as L. major and L.
mexicana are usually exclusively dermotropic, while L.
infantum and L. donovani are responsible for both cutane-
ous and visceral leishmaniasis [5]. Apart from a general
species-specific organ tropism of Leishmania, intraspecies
intrinsic characteristics are also a relevant factor to con-
sider. According to Maia et al. [6], dermotropic and
viscerotropic L. infantum strains modulate the sand fly
biting time on the host leading to the delivery, respect-
ively, of a high or low dose of metacyclic promastigotes
into the skin which will impact on the parasite tropism
and manifestation of the disease. Even strains belonging
to the same zymodeme have been associated to differen-
tial infectivity [7].
In experimental infections, however, another parasite-
related feature is of major importance. In vitro cultiva-
tion of Leishmania is a subject open to wide variation
between laboratories, making the comparison of similar
experiments ambiguous. Depending on the culture
medium (Santarém, N. and Cunha, J., submitted results
and [8]), the duration of the culture [9] and the number
of axenic passages performed [9], the promastigotes gen-
erated will be differentially enriched in metacyclic forms
[9], which will condition the success of the infection.
Nonetheless, the genetics and the immune status of the
host play a similarly important role in the tropism and
severity of the disease [10]. In the murine models, L.
major was only found in the infection site of the resist-
ant C57BL/6 mice after subcutaneous injection, whereas
the same experimental protocol followed in the suscep-
tible BALB/c strain allowed visceralization [11]. Also,
high and low infective strains maintained their profile
(visceralizing or regulatory, respectively) in BALB/c and
C.B-17 SCID mice, although with higher parasite loads
in the T and B cell-dysfunctional SCID animals [12].
The analysis of HIV/Leishmania-coinfected human pa-
tients brought important insights into the role of the im-
mune system on the severity of the disease. On the one
hand the visceralization of dermotropic strains is fre-
quently observed in HIV/Leishmania-coinfections [13],
as well as the regular presence of amastigotes in uncom-
mon locations such as the lungs or the intestine [14].
On the other, the appearance of unique Leishmania
zymodemes in HIV+ patients has been reported, which
may be indicative of circulating strains normally associ-
ated with asymptomatic disease in immunocompetentpatients [13,15]. Some studies have shown that strains
originating from HIV+ patients have low infectivity,
which explains its appearance only in immunocomprom-
ised individuals [7,16]. On the contrary, three distinct in-
fective profiles were attributed to strains responsible for
CL or VL (from immunocompetent or HIV+ patients) and
no correlation was made according to the origin of the
isolate [17].
In this study, we have focused on four different L.
infantum strains isolated from patients with CL, VL and
HIV/Leishmania coinfections. We characterized these
strains according to molecular, biological and infectivity
characteristics. We standardized the in vitro culture to
avoid any biased infectivity that was evaluated with
macrophage and mouse models. We have studied the
distribution of the strains in acute and chronic infection
by qPCR assessing the parasite load in spleen, liver,
bone marrow, blood and lymph nodes and correlated




Four L. infantum strains isolated from patients in the
Mediterranean basin and Portugal were used in this study.
MHOM/MA/67/ITMAP-263 (ST) is a cloned line derived
from a patient with visceral leishmaniasis [9,18] that was
used as an internal and comparative control in all the ex-
periments performed. HL strain (MHOM/PT/2009/LLM-
1708) was isolated from an immunocompetent patient
with cutaneous leishmaniasis. Briefly, a skin biopsy was
dissociated in a cell strainer to isolate the cells and was
then transferred into culture in RPMI. E390M (MHOM/
ES/99/LLM-855) and Bibiano (MHOM/ES/01/LLM-1083)
were isolated from bone marrow aspirates of HIV/Leish-
mania-coinfected patients, this second one being respon-
sible for recurrent relapses of leishmaniasis. The bone
marrow samples were cultivated in NNN medium at 26–
27°C, until the expansion of the promastigotes. ST, HL
and Bibiano strains have been characterized by multilocus
enzyme electrophoresis (MLEE) as MON-1 zymodeme,
while E390M is MON-284 (electrophoretic mobilities for
malate dehydrogenase (MDH) and glucose-phosphate
isomerase (GPI) were determined to be of 104 and 105,
respectively, in relation to MON-1 zymodeme [13]).
Molecular typing
L. infantum isolates were subjected to molecular typing
by targeting four different regions of the Leishmania
genome. Leishmania DNA was extracted by phenol/
chloroform as described below in more detail and sam-
ples were adjusted to a final concentration of 10 ng/μL
after measuring DNA content with a Nanodrop ND-
1000 spectrophotometer (Thermo Scientific). A volume
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products were run on 2% agarose gels stained with eth-
idium bromide and visualized under UV light. Then they
were excised from agarose gels and purified using the
QIAquick Gel Extraction Kit (QIAGEN). First, the spe-
cies status of the isolates was confirmed by DNA se-
quencing of the heat-shock protein 70 (hsp70) gene [19].
Further subtyping was performed by sequence analysis
of the ribosomal internal transcribed spacer 1 (ITS1)
and 2 (ITS2) [20] and the hydrophilic acylated surface
protein B (haspB) or k26 gene [21]. The Big-Dye Ter-
minator Cycle Sequencing Ready Reaction Kit V3.1 and
the automated ABI PRISM 377 DNA sequencer (Applied
Biosystems) were used for direct sequencing of the k26,
ITS1 and ITS2 PCR products that was performed with
the corresponding forward and reverse primers; internal
primers for sequencing were also used for the hsp70
PCR product, as described by Fraga et al. [19]. The
obtained sequences were analyzed and edited using the
software BioEdit Sequence Alignment Editor, version
7.0.9.0 (Ibis Biosciences) [22]. ClustalW multiple align-
ment algorithm tool and manual adjustment were used
for comparison of the resulting sequences with the re-
spective published sequences. The hsp70 sequences were
compared with those of the different Leishmania species
generated by Fraga et al. [19]. ITS types were assigned
to each isolate according to the sequence polymorphism
of the 12 microsatellite regions included in ITS1 (four
sites) and ITS2 (eight sites), as described by Kuhls et al.
[20]. k26 genotypes were assigned according to the size
and sequence of the PCR product, following the criteria
previously described by Haralambous et al. [21].
For the generation of unique patterns that could be
used for strain identification, we amplified a region of
the kinetoplast DNA minicircles and evaluated the re-
striction profile after HaeIII (Roche Applied Science)
endonuclease digestion [23] using DNA extracted from
axenic promastigotes and from experimentally infected
murine tissues.
Culture media
Novy-MacNeal-Nicolle medium (NNN) was prepared with
a semi-solid phase made of 1.4% agar (Sigma-Aldrich),
0.6% NaCl (Merck), 31% defibrinated rabbit blood, 625
units/mL penicillin, 625 units/mL streptomycin and RPMI
1640 medium supplemented with 10% fetal bovine serum
(FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 U/mL
streptomycin and 20 mM HEPES buffer (all from Lonza)
as liquid phase.
Growth curves and viability
Parasites were first passed in mice to control their viru-
lence and frozen in vials for future use until 10 in vitro
passages [9]. Promastigotes were cultivated at 26°C withan initial inoculum of 106 parasites/mL in NNN from a
synchronized culture in the same media and followed
for 6 days. In each day, parasites were counted in a
hemocytometer and stained with Annexin V and 7-
amino-actinomycin D (7-AAD) for viability analysis as
described in [9]. 10 000 gated events were analyzed in a
FACSCanto II (BD Biosciences) and the percentage of
Annexin-/7AAD- cells determined with FlowJo software
(TreeStar).
Cell cycle
In each day of culture, promastigotes were recovered and
washed in PBS/FBS 2%. 2×106 parasites were resuspended
in 1 mL of PBS/FBS 2% and 3 mL of ice-cold absolute
ethanol (Panreac) was carefully added while vortexing.
After fixation for 1 hour at 4°C, the parasites were washed
in PBS and resuspended in 1 mL of propidium iodide (PI)
staining solution consisting of citrate buffer 3.8 mM in
PBS, 50 μg/mL PI (Sigma-Aldrich) and 0.5 μg/μL RNAse
A (Sigma-Aldrich). Following an incubation of 30 minutes
at 4°C, 20 000 single live cells were acquired in a
FACSCanto II and analyzed with the FlowJo’s cell cycle
built-in tool.
Quantification of metacyclogenesis-dependent gene
transcription
107 promastigotes from day 1 to 6 of culture were
resuspended in TRIzol reagent (Invitrogen) and frozen
at −80°C. Total RNA was extracted using chloroform
and isopropanol according to the manufacturer’s in-
structions and solubilized in 10 μL of nuclease-free
water. RNA of high quality was obtained (RQI between
9.0 and 10.0) as assessed using RNA StdSens Chips of
the Experion automated electrophoresis system (Bio-
Rad). RNA concentration was determined using a
Nanodrop ND-1000 spectrophotometer. Samples were
stored at −80°C until cDNA was synthesised. Reverse
transcription was performed with iScript cDNA synthesis
kit (Bio-Rad) according to the manufacturer’s instructions
over 500 ng of total RNA. Meta-1, Small Hydrophilic
Endoplasmic Reticulum-associated Protein (SHERP) and
histone H4 transcription was quantitatively analyzed after
normalization with rRNA45 transcription by qPCR using
the iQ SYBR Green Supermix according to the manufac-
turer’s instructions in a My iCycler iQ5 (Bio-Rad). 4 μL of
cDNA (diluted 25×) was used as template that was run in
duplicate with 500 nM (Meta-1 and histone H4) or 250
nM (SHERP and rRNA45) of the following primers (from
Stabvida): Meta-1 [GenBank: NC_009401] forward: 5′-
GGGCAGCGACGACCTGAT-3′ and reverse: 5′-CGTC
AACTTGCCGCCGTC-3′ (modified from [24]); histone
H4 [LinJ35.1400, GenBank: XM_001468907] forward: 5′-
ACACCGAGTATGCG-3′ and reverse: 5′-TAGCCGTA
GAGGATG-3′ [9]; SHERP [GenBank: XM_003392466]
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reverse: 5′-TACGAGCCGCCGCTTATCTTGTC-3′ [9];
rRNA45 [GenBank: CC144545] forward: 5′-CCTACCA
TGCCGTGTCCTTCTA-3′ and reverse: 5′-AACGACCC
CTGCAGCAATAC-3′ [25]. Changes in relative gene
expression were determined with ΔΔCT method and re-
sults show fold changes comparative to day 1 calculated
by 2-ΔΔCT.
In vitro infections
Bone marrow-derived macrophages (BMMo) were pro-
duced as described previously [9]. Stationary promas-
tigotes cultivated in NNN for 4 days were washed and put
in contact with the cells in 1:10 ratio (cell:parasites) for
4 hours. Extracellular parasites were washed away with
PBS and the cells incubated for more 24, 48, 72 or
96 hours or fixed immediately with 2% PFA. The macro-
phages were mounted on Vectashield with DAPI (Vector
Laboratories) and 100 infected cells or 400 total cells were
counted in duplicate by fluorescence microscopy in a
Zeiss Axioskop (Carl Zeiss). The percentage of infected
cells and the geometric mean of the number of parasites
per infected cell were evaluated. The infection index was
calculated by multiplication of both parameters to account
for the overall parasite load.
In vivo infections
7–8 week-old BALB/c male mice (4–5 animals per
group, except in 2-week infections with E390M strain
where only 3 animals were used) were infected via the
intraperitoneal route with 108 promastigotes of each strain
cultivated in NNN for four days. After 2 or 6 weeks of
infection mice were anesthetized with isoflurane and
sacrificed by cervical dislocation. Blood, inguinal lymph
nodes, spleen, liver and femoral bone marrow were recov-
ered for quantification of parasite load. Blood and spleen
were also used for the evaluation of humoral and cellular
responses.
Parasite load quantification
Parasite load was quantified in samples that were col-
lected and frozen at the time of animal sacrifice. We
used 200 μL of blood collected with EDTA, 10 mg of
spleen and liver (single cell suspensions), 3 × 106 bone
marrow cells and the inguinal draining lymph node to
extract DNA. First, 400 μL of a buffer containing 10 mM
NaCl, 10 mM EDTA and 10 mM Tris–HCl with pH 8.0
were added to the samples, which were incubated over-
night with 40 μg of proteinase K (Sigma-Aldrich) at 56°C
with shaking. Then, the samples were vortexed and
incubated for 20 minutes at 70°C. DNA was extracted
using phenol/chloroform/isoamyl alcohol (all from Merck
Millipore). After precipitation with ice-cold 70% ethanol
solution, DNA was dissolved in 100–200 μL of nuclease-free water. We quantified the total DNA in a Nanodrop
ND-1000 spectrophotometer and prepared dilutions of
concentrations adjusted for each tissue. We quantified
Leishmania sp. DNA by qPCR using 1000 nM of R223
and 500 nM of R333 primers (Sigma-Aldrich) for the
small subunit rRNA (SSUrRNA) [26]. Depending on the
tissue, 100 to 400 ng of total DNA served as a template in
a 20 μL reaction using LightCycler FastStart DNA Master
SYBR Green I kit (Roche Applied Science) according to
the manufacturer’s instructions, in a touchdown qPCR
performed in a LightCycler 2.0 carousel-based instrument
(Roche Applied Science) with final annealing temperature
of 65°C [27]. CTs were extrapolated in a standard curve
constructed with serial dilutions of L. infantum DNA
(strain JPC, MCAN/ES/98/LLM-722) diluted in host
DNA (from spleen of naïve mice) to calculate Leishmania
content in parasites/μg DNA. Whenever the qPCR gave a
positive (with the expected melting curve) but unquantifi-
able value or a doubtable specific product (aberrant melt-
ing curve), we performed a nested PCR [28] that has a
higher sensitivity (0.01 parasites) than the qPCR (0.6 para-
sites) to confirm the positivity of the quantitative result.
300 nM of R221 and R332 primers [26] were used for the
first amplification reaction. For the second reaction, 10 μL
of the first PCR product diluted 1:40 served as template
with the same R223 and R333 primers (300 nM and 150
nM, respectively) used for the qPCR. This molecular
quantification was applied after proper validation by com-
parison with limiting dilution assay (Additional file 1:
Additional Methods and Additional file 2: Figure S1).
Splenic cell populations
5 × 105 splenocytes were surface-stained for 20 minutes
at 4°C with saturating concentrations of monoclonal
antibodies (all from Biolegend). After washing twice with
PBS/FBS 2%, the cells were examined by flow cytometry
in a FACSCanto (BD Bioscences) and analyzed with
FlowJo software. After acquisition of 50000 cells identi-
fied by FSC and SSC parameters, major populations
were identified as follows: CD4+ T lymphocytes (PerCp.
Cy5.5 anti-CD3, clone 17A2; APC.Cy7 anti-CD4, clone
GK 1.5), CD8+ T lymphocytes (PerCp.Cy5.5 anti-CD3;
FITC anti-CD8, clone 53–6.7), B cells (FITC anti-CD19,
clone 6D5), monocytes/macrophages (PE.Cy7 anti-CD11b,
clone M1/70; PerCp.Cy5.5 anti-Ly6C, clone HK1.4).
Leishmania-specific immunoglobulins
The specific humoral response was analyzed by ELISA
as described elsewhere [18]. In short, 96-well microtitration
plates (Greiner Bio-One) were coated with 10 μg/mL of
soluble Leishmania antigens (SLA) in carbonates buffer
pH 8.5 and then blocked with PBS/gelatin 1%. Sera were
diluted 1:100 and incubated for 2 hours at 37°C. After
washing with PBS/tween 20 0.1%, HRP-conjugated anti-
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wells at a dilution of 1:5000 and incubated for 30 minutes
at 37°C. The plates were revealed with 0.5 mg/mL of o-
phenylenediamine dihydrochloride (Sigma-Aldrich) in cit-
rate buffer pH 4.0 and the reaction was stopped with HCl
3 N. The absorbance was read at 492 nm in a Synergy 2
microplate reader (Biotek).
Animals and ethics statement
For the in vitro experiments we used 10–12 week-old
female BALB/c mice bred and maintained at IBMC -
Instituto de Biologia Molecular e Celular (Portugal) ani-
mal facilities. For the in vivo experiments 7–8 week-old
male BALB/c mice were bred and maintained at the
Instituto de Salud Carlos III (Spain) animal facilities.
Mice were housed in IVC cabinets with sterile food and
water ad libitum. All experiments conducted were car-
ried out in accordance with the IBMC.INEB and ISCIII
Animal Ethics Committees and the Portuguese and
Spanish National Authorities for Animal Health guide-
lines that follow the statements on the directive 2010/
63/EU of the European Parliament and of the Council.
ACS has an accreditation for animal research given from
Portuguese Veterinary Direction (Ministerial Directive
1005/92).
Statistical analysis
GraphPad Prism 5 (GraphPad Software) was used to
perform all the statistical analysis. The results are
presented as means ± standard deviations (SD). To com-
pare statistical differences between means two-sided t
test or one-way ANOVA followed by Dunnett’s multiple
comparison test were run when comparing 2 or more
groups, respectively, unless otherwise stated. * p < 0.05,
** p < 0.01 and *** p < 0.001.
Results and discussion
Molecular characterization of the clinical isolates of L.
infantum
To understand the intraspecies polymorphisms and its
possible impact on both in vitro and in vivo infectivity,
we characterized certain molecular aspects of these four
L. infantum strains.
A molecular approach was followed by us aiming not
only to confirm the identity [19] of Bibiano, E390M and
HL strains, together with the laboratory’s standard L.
infantum (ST) strain, but also to subtype the isolates
according to Haralambous et al. [21] and Kuhls et al. [20].
Molecular genotyping of the strains indicated that all four
were 100% consistent with L. infantum and were clustered
in the same ITS type A group (data not shown), which is
the most common in specimens from the Mediterranean
area even within different zymodemes [20]. Moreover,
Bibiano, HL and ST were classified in the k26 group 1b,the most frequent in the Iberian Peninsula [21], while
E390M belongs to a new k26 group reported here for the
first time, since it returned an 836 bp amplicon [GenBank:
KC576808] never found before (Figure 1A and Additional
file 3: Figure S2).
PCR-RFLP of kinetoplast DNA minicircles was used as
a tool for creating an individual identity for each strain.
Because we were working with L. infantum strains that
preferably could have similar growth and morphology,
they would be indistinguishable in in vitro cultures. In
case of cross-contaminations between strains [29,30], we
would like to have a tool for identification of our parasites.
All the strains showed very complex profiles (Figure 1B),
but each one of the specimens was clearly identifiable by
the examination of the most intense bands.
Characterization of biological features of the
promastigotes generated in vitro
In vitro cultivation has a major impact on the virulence
of the pathogens due to intrinsic properties of the culture
media that modulate Leishmania infectivity (Santarém, N.
and Cunha, J., submitted results and [8,31]), or to the loss
of adaptive capacities to mammalian host cells resulting
from long-term in vitro cultivation of promastigotes. A
relevant experimental bias can be introduced if these fac-
tors are not considered. Hence, the comparison of the in-
fective capacity of distinct strains should take into account
the adaptation to culture conditions and/or the axenic
growth behavior [7,32].
We started to characterize the axenic growth of the
four L. infantum strains. Aiming to identify any differ-
ence in their infectivity that could justify the dissimilar
outcomes of the disease in the natural infections, we first
had to understand what specific nutritional needs the
parasites might have in order to standardize the in vitro
culture conditions. Preliminary experiments with para-
sites cultivated in RPMI medium exposed remarkable
differences among the growth of each L. infantum strain
(data not shown). Attempts to find a culture medium
suitable for the continuous and comparable growth of
the four strains included doubling the FBS content to
20% and adding glucose to RPMI medium, the use of
Schneider’s Insect medium and the preparation of a mix-
ture of RPMI and Schneider media in equal parts (data
not shown; the composition of these culture media is
detailed in Additional file 1: Additional Methods). How-
ever, only the use of Novy-MacNeal-Nicolle medium
(NNN) allowed us to guarantee an in vitro homogeneous
culture condition where all four strains could be easily
cultivated, maintained and have a similar development
that would allow the direct comparison of strain infect-
ivity. Bibiano, E390M, HL and ST strains showed per-
fectly overlapped growth curves in NNN (Figure 2A),
with morphologically indistinguishable promastigotes
Figure 1 Molecular characterization of L. infantum isolates. (A) Amplification of the k26 gene. See Additional file 3: Figure S2 for coding DNA
sequences and alignment. (B) RFLP patterns for L. infantum isolates after HaeIII digestion of an amplified fragment of the minicircles kDNA.
Profiles for DNA extracted from axenic promastigotes are shown, though DNA from experimentally infected murine tissues delivered comparable
restriction patterns. For each strain, left lane corresponds to the digested DNA and right lane to undigested product. Gels were prepared with 2%
(A) or 2.5% (B) agarose and stained with ethidium bromide. MW - molecular weight marker with bp units assigned in the left of the figure.
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fourth day of culture (Figure 2B).
The culture of all promastigote strains in NNN en-
abled a rapid exponential parasite growth that peaked at
day 3 (≈108 parasites/mL) after which it stabilized untilFigure 2 In vitro development of L. infantum strains. (A) Growth curve
infantum strains in NNN. Cultures were started with 106 promastigotes of e
counting of parasite numbers in a Neubauer chamber. (B) Parasite viability
mean of three independent experiments is plotted; bars represent SD. (C)
one representative experiment of three independent assays. (D) Illustrative
captured by flow cytometry.day 6. These timings could be confirmed by the analysis
of the cell cycle (Figure 2C and Additional file 4: Figure
S3). On the first day of culture, around 50% of the para-
sites were in S/G2 phases in a clear indication of active
proliferation. From the third day on, only ≈ 20% of thes of Bibiano (light grey), E390M (dark grey), HL (black) and ST (white) L.
ach strain per mL and growth was followed for a week, with a daily
measured by flow cytometry as percentage of AnnV-/7AAD- cells. The
Cell cycle analysis of HL during growth period. Data show means of
phenotype of L. infantum promastigotes with 4 days of culture in NNN
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stationary phase promastigotes with small bodies and
large flagella could be clearly identified by optic micros-
copy (data not shown); these were confirmed by flow cy-
tometry (Figure 2D) as FSCloPI- cells [33,34]. Based on
this typical morphology of metacyclic promastigotes, we
analyzed metacyclogenesis throughout the 6 days of cul-
ture by quantifying the expression of specific genes which
are upregulated (Meta-1 and SHERP) or downregulated
(histone H4) during the process [25,33,35] (Figure 3 and
Additional file 5: Figure S4). Despite the observed inter-
strain variations on the fold modifications of each gene, all
of the strains showed a dramatic decrease in histone H4
expression consistent with the cell cycle analysis. For
Bibiano, Meta-1 gene expression significantly increasedFigure 3 Indirect measurement of metacyclogenesis. Quantification of
the time of culture in NNN medium for the four strains. Bars represent the
experiments. Statistical significant differences between day 1 and the follow
multiple comparison test.every day of culture, while for E390M the major fold
changes were detected in the SHERP gene expression.
Both Meta-1 and SHERP increased overtime for HL and
ST until day 4 and after that they recovered to levels
close to those of day 1. We cannot directly compare the
metacyclogenesis process between the four strains, but
we must take into account the total information avail-
able to affirm that these promastigotes were differentiat-
ing into metacyclic forms. The leading factor is that the
overall analysis of the three genes studied pointed to-
wards metacyclogenesis. This trend could be better
understood when calculating the ratio between the up
and downregulated genes (Additional file 5: Figure S4),
as all the strains presented an increase in the ratios over
the 6 days of culture.(A) Meta-1, (B) SHERP and (C) histone H4 transcription by RT-PCR over
mean fold change relative to day 1 with SD of two independent
ing days were determined with One-way ANOVA and Dunnett’s
Cunha et al. Parasites & Vectors 2013, 6:122 Page 8 of 14
http://www.parasitesandvectors.com/content/6/1/122Evaluation of the infectivity of L. infantum isolates
To evaluate parasite infectivity, we infected macrophages
and followed the progression of the infection for four
days (Figure 4). At the initial time-point, the four strains
infected approximately all the cells without any differ-
ences in the total percentage of infected macrophages
(Figure 4A). However, when evaluating the parasite load
in each infected cell, HL promastigotes were more ef-
fective in the invasion of the macrophages with a mean
of 12 ± 1.5 parasites in each infected cell versus 3 to 5 par-
asites found for the other strains (Figure 4B). After the
first 24 hours, an accentuated reduction in the infectionFigure 4 In vitro differential infectivity of L. infantum strains. BMMo w
in NNN in a ratio of 10:1 (parasites:macrophage). The kinetics of infection w
parasites per infected cell on fluorescent microscope. To account to the ov
the individual data from (A) by (B). Statistically significant differences betwe
followed by Tukey’s multiple comparison test.index was detected for the four strains (Figure 4C), which
was maintained, though softened, during the entire period
of the assay. Nevertheless, HL parasites were more resist-
ant to macrophage-specific killing machinery as displayed
by the increased infection index throughout the study. For
this reason, this strain was considered to be more infective
than the ST virulent strain [36,37]. Interestingly, 72 and
96 hours post-infection, macrophages could harbor sig-
nificantly more Bibiano than ST parasites, though it did
not translate into a higher overall parasite load as shown
for HL (Figure 4C) because of the low percentage of
infected cells.ere infected with promastigotes of each strain after 4 days of culture
as followed counting (A) the infected cells and (B) the number of
erall parasite load, an infection index (C) was calculated multiplying
en ST and the other strains were determined with One-way ANOVA
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http://www.parasitesandvectors.com/content/6/1/122As is well known, disease manifestation depends on
the virulence of Leishmania strain [12,17] but also on
the genetic background [38] and immune status of the
host [14,39]. Hence, the differences in infectivity detected
in vitro were explored in the BALB/c model of visceral
leishmaniasis to evaluate the influence of the parasites’ in-
trinsic characteristics in the ability to cause the disease.
We therefore studied parasitological and immunological
features in the acute and chronic phases of infection. Para-
site load was quantified in the spleen, liver and bone mar-
row as the main target organs in this model. The presence
of Leishmania in the draining lymph nodes and the blood
were also investigated (Figure 5).
In the acute phase, 2 weeks after the infection, no
significant differences were calculated between the four
strains in all the five tissues studied. Despite the lack of
statistical significance, important differences could be
appreciated between strains. In the visceral organs
(Figures 5A and B), HL and Bibiano showed very similar
parasite burden, representing the most infective strains
in these tissues. As compared to ST, they presented overFigure 5 Quantitative distribution of L. infantum in BALB/c mice 2 an
(A) spleen, (B) liver, (C) bone marrow, (D) lymph node and (E) blood. Data
experiment of two independent assays. T test was used to determine statis
each strain; * p < 0.05. With one-way ANOVA followed by Tukey’s multiple
between strains at each time point; # p < 0.05. Dashed line indicate limit o1 logarithm higher parasite load in spleen and were ≈
800 times higher in the liver. ST was indeed the least effi-
cient strain colonizing these organs, as E390M was able to
infect almost 3 and 15 times more in the spleen and liver
of mice. In the inguinal lymph nodes (Figure 5D) and
the blood (Figure 5E), HL was the strain that showed
higher parasitism. Its values surmounted 14, 300 and
1100 times the burden of Bibiano, E390M and ST, re-
spectively, in the lymph nodes, and 3, 20 and 46 times,
respectively, in the blood. The bone marrow was more
infected by ST, though without accentuated differences
between the other strains (Figure 5C). After this ana-
lysis one could expect ST to be the least infective strain
in the acute phase of the disease, once HL was the
strain that showed higher infectivity in the majority of
the tissues examined, followed close by Bibiano. None-
theless, estimating the total number of parasites existing
in the whole animal, we calculated ≈ 5 × 108 ST para-
sites, approximately double the number estimated for
Bibiano and HL and over a logarithm more than E390M
(Table 1).d 6 weeks after infection. The parasite burden was quantified on the
represent means ± SD of 3–5 animals per group of a representative
tically significant differences between 2 and 6 weeks of infection with
comparison test we calculated statistically significant differences
f detection for quantification for each tissue.
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strains showed relative infection profiles in the spleen
(Figure 5A), bone marrow (Figure 5C) and lymph nodes
(Figure 5D) similar to the acute phase. As before, HL
was shown to be the most infective strain in spleen and
lymph nodes. In the bone marrow the differences were
once more not as accentuated between strains, although
the higher parasite loads were found in HL infected
mice. In the liver (Figure 5B), HL was still the most in-
fective strain, but Bibiano, which in the other tissues
presented comparable parasite loads, was, significantly,
the least infective strain, whereas E390M and ST pro-
duced intermediate infections. In the blood (Figure 5E),
the differences observed at 2 weeks post-infection were
neutralized, as the four strains showed similar levels of
circulating parasites.Distribution and compartmentalization throughout the
infection
Evaluating the progression of the disease, these four
strains depicted very different trends. In the acute phase
of infection, Bibiano and HL were found in very high
numbers in the visceral organs but evolved in the oppos-
ite directions with chronicity. Bibiano was efficiently
cleared from the liver, with a 425-fold reduction, though
in the spleen the parasite load did not alter. As to HL,
the liver infection was maintained and the splenic para-
site burden increased 5 times from 2 to 6 weeks after in-
fection, which showed not only high capacity to infect
but also to perpetuate in the host. E390M, on the con-
trary, showed a low infective phenotype, with the lowest
parasite loads in all the tissues quantified in the acute
phase of infection. Through time, this strain was not
able to proliferate in the spleen or in the bone marrow;
the parasites resisted in the liver and showed a 7.4-fold
increase in the blood. Despite with disparate initial para-
site loads (more than 6-fold difference), Bibiano and
E390M, both isolated from HIV+ patients, followed a
very similar trajectory in the progression of the diseaseTable 1 Estimated overall parasite load of L. infantum-infecte
Total parasite load 2 weeks post-infection
Bibiano E390M HL
Spleen 67.7 × 104 8.82 × 104 44.1 × 104 3
Liver 157 × 106 2.77 × 106 112 × 106 0
Bone marrow 15.0 × 107 4.49 × 107 11.9 × 107 5
Lymph nodes 4.83 × 104 0.19 × 104 67.0 × 104 0
Blood 0.97 × 103 0.42 × 103 19.4 × 103 0
Whole animal 3.08 × 108 0.48 × 108 2.32 × 108 5
Mean weights of spleen, liver and inguinal lymph nodes of the infected animals (Ad
volume of blood (1.8 mL) and total number of bone marrow cells (4.5 × 108) were eand, eventually, would be eliminated over time in these
immunocompetent BALB/c mice. The high parasitemia
presented by these two strains in the chronic phase may
facilitate the anthroponotic transmission of Leishmania
between the intravenous drug users (IVDUs) [42], one of
the populations with highest risk of HIV/Leishmania co-
infection [43]. Concerning ST, the standard virulent
strain in our laboratory, showed a clear tropism for the
bone marrow in the acute phase, with the lowest parasite
loads in the remaining organs compared to other strains.
However, 6 weeks post-infection, ST dramatically multi-
plied reaching levels ≈ 6- and ≈ 17-fold higher in the
spleen and liver, respectively.
As a final remark, this study allowed us to verify that
bone marrow parasite load is maintained in a range that
does not suffer major alterations either over-time nor is
it strain-dependent. Possibly this is the reason why bone
marrow aspirates are the eligible sample for leishmania-
sis diagnosis, either for microscopic analysis, culture or
molecular techniques [4].Infectivity relates to cell modulation
Along with the differences described in the parasite load,
we analyzed the weight of spleen and liver of the
infected animals and compared them with naïve mice
(Additional file 6: Figure S5A and B). In general, small
fluctuations were detected in the weight of the organs,
which followed the trends exposed above for the parasite
loads. Indeed, HL infected mice presented hepatos-
plenomegaly in the chronic phase of the disease, the
pathologic hallmark of visceral leishmaniasis (reviewed
in [44]). We attributed the splenomegaly not only to the
presence of elevated numbers of Leishmania but also to
the expansion of the main cellular populations detected
in the spleen (Figure 6). A significant increase in both
CD4+ and CD8+ T cells, B cells and macrophages was
quantified in mice infected for 6 weeks with HL, an incre-
ment that corresponded to double the numbers found in
the naïve mice. While the expansion of lymphocyted BALB/c mice 2 and 6 weeks post-infection
6 weeks post-infection
ST Bibiano E390M HL ST
.81 × 104 62.7 × 104 0.40 × 104 329 × 104 18.9 × 104
.14 × 106 0.35 × 106 2.54 × 106 86.8 × 106 2.42 × 106
0.9 × 107 13.9 × 107 2.29 × 107 18.1 × 107 11.7 × 107
.10 × 104 1.78 × 104 0.015 × 104 10.3 × 104 0.59 × 104
.32 × 103 6.54 × 103 3.12 × 103 1.95 × 103 4.53 × 103
.09 × 108 1.40 × 108 0.25 × 108 2.71 × 108 1.19 × 108
ditional file 6: Figure S5) were used in these calculations. Values for total
stimated as published elsewhere [40,41].
Figure 6 Cell populations in spleens of naive and Leishmania-infected mice in the acute and chronic phases. (A), (F) Total cells were
counted and stained for identification of major splenic populations by flow cytometry. (B), (G) CD4+ T cells. (C), (H) CD8+ T cells. (D), (I) B cells.
(E), (J) Monocytes/macrophages. (A)-(E) Absolute number of cells per spleen. Data represent means ± SD of 3 to 5 animals per group of one
experiment representative of two. (F)-(J) Fold modification of cell numbers in the infected mice in relation to naïve. Boxes and whiskers with
5–95 percentile and mean (showed by “+”) of 3 to 5 animals. Dashed and solid lines indicate a 2- or 4-fold modification, respectively, relative to
naïve mice. One-way ANOVA followed by Dunnett’s multiple comparison test was performed to calculate statistically significant differences
between naive and infected mice at 2 and 6 weeks after infection.
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immune responses, the presence and increase of CD11b
+Ly6C+ monocytes were recently described to play a
major role in the architectural remodeling of the spleen
during experimental visceral leishmaniasis, mainly in
the vascularization of the red pulp that accompanies
splenomegaly [45].The enlargement in the B cell population explains the
elevated titers of anti-Leishmania antibodies quantified
in the chronic infection by HL (Figure 7). Both IgG2a
and IgG1 were generated in high levels, leading to the
exacerbation of the pathology, as described by others
[46-48]. However, in E390M infections we did not detect
any B cell expansion, as measured at 2 weeks post
Figure 7 Leishmania-specific humoral response. Leishmania-specific sera reactivity of naive and infected animals 2 and 6 weeks post-infection
was analyzed by ELISA. Specific (A) IgG2a and (B) IgG1 were quantified and are depicted as means ± SD of one representative experiment of 2
independents. Statistically significant differences are pointed out as given by one-way ANOVA followed by Dunnett’s multiple comparison test.
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http://www.parasitesandvectors.com/content/6/1/122infection and later at 6 weeks, though IgG2a and IgG1
were significantly increased compared to age-matched
naïve mice. We speculate that this antibody production
could be in part related to the k26 gene. Leishmania k26
(also known as HASPB) protein, as well as SHERP that
share the same locus on chromosome 23 [49], are stage-
regulated proteins, expressed only in the mammalian host
infective forms (metacyclic promastigotes and amastigotes)
[50]. k26 has a central core composed of a 10–11 amino
acid repeats (PKEDGHTQKND/PKEDGRTQKN in Add-
itional file 3: Figure S2) which present high inter and
intra-specific variability [49,51,52], a feature that makes
it an interesting tool for molecular typing of different
Leishmania species and strains [21]. Other than this,
k26 is a highly immunogenic antigen [49] with proven
efficacy as a vaccine in murine models of visceral leish-
maniasis by L. donovani [51,53] and partial efficacy in
canine leishmaniasis by L. infantum [54]. Its immuno-
genic properties make k26 an interesting antigen that
has been studied for diagnostic purposes [55-57]. As we
reported in this work, E390M k26 protein has more re-
peats than MON-1 strains, which may influence the
type and the strength of the humoral response as those
amino acid repeats were determined to be B cell epi-
topes [52]. We point towards this argument since
Bibiano and ST strains, that proved to be more infective
than E390M, were not able to produce specific anti-
bodies nor increased splenic cellularity in the acute or
the chronic phases of murine VL.Conclusions
The molecular typing strategy confirmed the previous
zymodeme characterization by MLEE and provided fur-
ther knowledge that can be applied to diagnostics and
population genetics studies. In this sense, the k26 se-
quence for E390M strain generated in this work adds in-
formation for a zymodeme (MON-284) not included in
the study by Harambolous [21], thus contributing to k26
gene-based typing methodology, which is being usedincreasingly in population genetics and molecular epi-
demiology studies related to the L. donovani complex
[58,59]. Laboratory conditions for in vitro culture were
set to produce Bibiano, E390M, HL and ST fit pro-
mastigotes in the same developmental stage. In vivo in-
fections with HL confirmed the in vitro phenotype of
the most infective strain as more parasites were esti-
mated to be present in the whole animal. ST was also
considered to be highly infective though with a slower
progression over time. Bibiano and E390M, isolated
from HIV+ patients, showed differential infectivity and
immunomodulation that could be influenced by the ini-
tial compartmentalization in host tissues. Interestingly,
the most (HL) and the least (E390M) infective strains were
the most immunogenic, revealing high levels of anti-Leish-
mania IgG2a and IgG1, especially in the chronic phase of
infection.
This work is in line with previous studies [6,7,17,60]
that show that leishmaniasis is a multifactorial disease
and the broad spectrum of clinical manifestations de-
pends on the genetics and inherent characteristics of
the parasite coordinated with the susceptibility of the
host.Additional files
Additional file 1: Additional methods.
Additional file 2: Figure S2. Validation of the qPCR methodology for
quantification of the parasite loads in murine tissues. BALB/c mice were
infected for 2 weeks with 108 L. infantum strains (3 mice for each strain)
cultivated in an equivolumetric mixture of RPMI and Schneider for 5 days.
(A) Spleen and (B) liver were collected and cell suspensions were
prepared. Parasite loads were quantified by qPCR and compared with the
values obtained by limiting dilution assay.
Additional file 3: Figure S2. k26 gene alignment. Coding DNA
sequences (cds) were translated into amino acids and aligned with
standard sequences generated by Haralambous et al. [21] [GenBank:
EF504255 and EF504256]. Complete cds of k26 gene [GenBank:
XM_001465758.2] is aligned in the first row. The four L. infantum isolates
are aligned in the bottom rows. E390M k26 sequence was entered in the
GenBank with the access number KC576808.
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http://www.parasitesandvectors.com/content/6/1/122Additional file 4: Figure S3. Cell cycle analysis. (A) Representative
histograms of PI content at day 1 and 6 of promastigote culture. (B-D)
The percentage of (B) Bibiano, (C) E390M and (D) ST promastigotes in G1,
S or G2 phases of the cell cycle was determined at days 1 to 6 of culture
in NNN medium by flow cytometry after staining the parasites with a PI
solution. Three independent experiments were performed, one
representative experiment is shown.
Additional file 5: Figure S4. Variation of the transcription of
metacyclogenesis-dependent genes. Meta-1, SHERP and histone H4
transcription was quantified by RT-PCR over the time of culture in NNN
medium. To evaluate the progression of metacyclogenesis we related the
up-regulation of (A) Meta-1 and (B) SHERP with the down-regulation of
histone H4 applying a mathematical ratio. Bars represent the mean fold
change relative to day 1 with SD of two independent experiments.
Statistically significant differences between day 1 and the following days
were determined with One-way ANOVA and Dunnett’s multiple
comparison test.
Additional file 6: Figure S5. Organ weight 2 and 6 weeks post-
infection. Mice were sacrificed and (A) spleen, (B) liver and (C) inguinal
lymph nodes were collected and weighted. Data represent means ± SD
of 3–5 animals of one experiment representative of two. One-way
ANOVA followed by Dunnett’s multiple comparison test were run for
statistical analysis between groups in each time point.Competing interests
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